1. Home
  2. CLDI vs SOBR Comparison

CLDI vs SOBR Comparison

Compare CLDI & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

N/A

Current Price

$1.60

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

N/A

Current Price

$0.57

Market Cap

2.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
CLDI
SOBR
Founded
2014
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.4M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
CLDI
SOBR
Price
$1.60
$0.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.5M
1.2M
Earning Date
05-14-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
103.55
EPS
N/A
N/A
Revenue
$45,000.00
$437,421.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
105.62
52 Week Low
$0.09
$0.35
52 Week High
$5.12
$3.95

Technical Indicators

Market Signals
Indicator
CLDI
SOBR
Relative Strength Index (RSI) 76.29 45.09
Support Level $1.17 $0.50
Resistance Level $1.62 $0.62
Average True Range (ATR) 0.14 0.05
MACD 0.04 0.01
Stochastic Oscillator 81.49 51.91

Price Performance

Historical Comparison
CLDI
SOBR

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

About SOBR SOBR Safe Inc.

Sobr Safe Inc is a hardware and software company. The Company integrates proprietary software, SOBRsafeTM, with its patented touch-based personal alcohol awareness tracking products, SOBRcheckTM and SOBRsure, enabling non-invasive personal alcohol awareness tracking, biometric identity verification, and qualified, real-time cloud-based, informational alerts and reporting. It operates as a single segment designed to enable customers to purchase products directly through channel partners, sales agents or through its enterprise and consumer digital channels. Currently its principal markets are located in North America.

Share on Social Networks: